Macquarie Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-518
| Closed | -$2.9K | – | 1968 |
|
|
2024
Q2 | $2.9K | Buy |
+518
| New | +$2.9K | ﹤0.01% | 1771 |
|
|
2022
Q4 | – | Hold |
0
| – | -$12K | – | 2434 |
|
|
2022
Q3 | – | Sell |
-453
| Closed | -$20K | – | 2326 |
|
|
2022
Q2 | $20K | Hold |
453
| – | – | ﹤0.01% | 2316 |
|
|
2022
Q1 | $22 | Hold |
453
| – | – | ﹤0.01% | 2368 |
|
|
2021
Q4 | $23K | Hold |
453
| – | – | ﹤0.01% | 2365 |
|
|
2021
Q3 | $25K | Hold |
453
| – | – | ﹤0.01% | 2404 |
|
|
2021
Q2 | $19K | Hold |
453
| – | – | ﹤0.01% | 2375 |
|
|
2021
Q1 | $19K | Sell |
453
-215
| -32% | -$9.02K | ﹤0.01% | 2306 |
|
|
2020
Q4 | $31K | Hold |
668
| – | – | ﹤0.01% | 2145 |
|
|
2020
Q3 | $28K | Hold |
668
| – | – | ﹤0.01% | 2088 |
|
|
2020
Q2 | $32K | Sell |
668
-2,032
| -75% | -$97.3K | ﹤0.01% | 2038 |
|
|
2020
Q1 | $124K | Hold |
2,700
| – | – | ﹤0.01% | 1575 |
|
|
2019
Q4 | $162K | Hold |
2,700
| – | – | ﹤0.01% | 1669 |
|
|
2019
Q3 | $153K | Sell |
2,700
-2,300
| -46% | -$130K | ﹤0.01% | 1644 |
|
|
2019
Q2 | $278K | Buy |
+5,000
| New | +$278K | ﹤0.01% | 1497 |
|
|
2019
Q1 | – | Sell |
-100
| Closed | -$4K | – | 2101 |
|
|
2018
Q4 | $4K | Sell |
100
-200
| -67% | -$8K | ﹤0.01% | 2142 |
|
|
2018
Q3 | $21K | Sell |
300
-1,200
| -80% | -$84K | ﹤0.01% | 1900 |
|
|
2018
Q2 | $113K | Buy |
1,500
+1,200
| +400% | +$90.4K | ﹤0.01% | 1813 |
|
|
2018
Q1 | $16K | Sell |
300
-3,100
| -91% | -$165K | ﹤0.01% | 2102 |
|
|
2017
Q4 | $182K | Sell |
3,400
-1,900
| -36% | -$102K | ﹤0.01% | 1756 |
|
|
2017
Q3 | $316K | Buy |
+5,300
| New | +$316K | ﹤0.01% | 1599 |
|